Diagenode SA
100.5 FTEThe score of Diagenode shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -64 % Equity -24 % Total assets -4 % Headcount (avg FTE) -8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Diagenode's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €11.9m | ||||
| Net result | −€2.95m | ||||
| Equity | €8.70m | ||||
| Cash | €1.21m | ||||
| EBITDA | −139,636 € | ||||
| Total assets | €21.1m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 02 Mar 2026
- Year ended 30 Sep 2024filed on 24 Apr 2025
- Year ended 30 Sep 2023filed on 06 Mar 2024
- Year ended 30 Sep 2022filed on 14 Mar 2023
- Year ended 31 Mar 2021filed on 30 Sep 2021
Diagenode's financial analysis
- Solvency41.3%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Diagenode
Diagenode's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0480.422.786
- VAT number
- BE0480422786
- Peppol
- Registered · 0208:0480422786 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 May 2003
- Registered office
- 4102 Seraing
- Size
- Medium · 100.5 FTE
- Latest accounts
- 2025 · filed on 02 Mar 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Diagenode (SA) has been based in Seraing since 2003, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €11.9m, a net loss of €2.95m and equity of €8.70m. With 100.5 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 41.3%, below the median of its sector (58.2%).
Companies similar to Diagenode
Companies in the same business, of comparable size and area, outside its group.
- LaCAR MDx technologies Manufacture of other special-purpose machinery n.e.c. Liège · balance sheet €29.1m
- Sartorius Xpress Biologics Manufacture of basic pharmaceutical products Herstal · balance sheet €10.9m
- Unisensor Manufacture of basic pharmaceutical products Seraing · balance sheet €19.2m
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Univercells Technologies Manufacture of other chemical products n.e.c. Nivelles · balance sheet €16.2m
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
- PharmaFluidics Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.4m
- Ogeda Research and experimental development on natural sciences and engineering Vilvoorde · balance sheet €53.5m
Frequently asked questions about Diagenode
What is the revenue of Diagenode?
According to the 2025 annual accounts filed with the NBB, the revenue of Diagenode amounts to 11,857,386 €.
What is the VAT number of Diagenode?
In Belgium, the VAT number is the company number prefixed with BE: BE0480422786 for Diagenode, if the company is VAT-registered. Its company number (CBE) is 0480.422.786.
Where is the registered office of Diagenode?
According to the CBE register, the registered office of Diagenode is in 4102 Seraing.
What is the equity of Diagenode?
At the close of the 2025 financial year, the equity of Diagenode amounts to 8,701,475 €, a solvency of 41.3% of total assets.
How many people work at Diagenode?
100.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Diagenode?
The register lists 4 active mandates at Diagenode. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Diagenode
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →